{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T23:06:12Z","timestamp":1792623972557,"version":"4.5.0"},"reference-count":64,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T00:00:00Z","timestamp":1696982400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Non-alcoholic fatty liver disease (NAFLD) is a multifactorial disease. As a clinical empirical prescription of traditional Chinese medicine, Qushi Huayu decoction (QHD) has attracted considerable attention for its advantages in multi-target treatment of NAFLD. However, the intervention mechanism of QHD on abnormal lipid levels and gut microbiota in NAFLD has not been reported.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Therefore, we verified the therapeutic effect of QHD on high-fat diet (HFD)-induced NAFLD in rats by physiological parameters and histopathological examination. In addition, studies on gut microbiota and serum lipidomics based on 16S rRNA sequencing and ultra-high performance liquid chromatography-mass spectrometry (UPLC-MS) were conducted to elucidate the therapeutic mechanism of NAFLD in QHD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The changes in gut microbiota in NAFLD rats are mainly reflected in their diversity and composition, while QHD treated rats restored these changes. The genera <jats:italic>Blautia, Lactobacillus, Allobaculum, Lachnoclostridium<\/jats:italic> and <jats:italic>Bacteroides<\/jats:italic> were predominant in the NAFLD group, whereas, <jats:italic>Turicibacter, Blautia, Sporosarcina, Romboutsia, Clostridium_sensu_stricto_1, Allobaculum<\/jats:italic>, and <jats:italic>Psychrobacter<\/jats:italic> were predominant in the NAFLD+QHD group. Lipid subclasses, including diacylglycerol (DG), triglycerides (TG), phosphatidylethanolamine (PE), phosphatidylcholine (PC), phosphatidic acid (PA), phosphatidylserine (PS), lysophosphatidylinositol (LPI), and phosphatidylglycerol (PG), were significantly different between the NAFLD and the control groups, while QHD treatment significantly altered the levels of DG, TG, PA, lysophosphatidylcholine (LPC), lysophosphatidylethanolamine (LPE), and platelet activating factor (PAF). Finally, Spearman\u2019s correlation analysis showed that NAFLD related differential lipid molecules were mainly associated with the genera of <jats:italic>Bacteroides, Blautia, Lachnoclostridium, Clostridium_sensu_stricto_1<\/jats:italic>, and <jats:italic>Turicibacter<\/jats:italic>, which were also significantly correlated with the biological parameters of NAFLD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>Taken together, QHD may exert beneficial effects by regulating the gut microbiota and thus intervening in serum lipids.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2023.1272214","type":"journal-article","created":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T10:47:58Z","timestamp":1697021278000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":18,"title":["Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids"],"prefix":"10.3389","volume":"14","author":[{"given":"Yiming","family":"Ni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Gou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,10,11]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2016-312729","article-title":"Gut microbiome and liver diseases","volume":"65","author":"Tilg","year":"2016","journal-title":"Gut"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.28709","article-title":"Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives","volume":"65","author":"Arab","year":"2017","journal-title":"Hepatology"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31115","article-title":"Indole alleviates diet-induced hepatic steatosis and inflammation in a manner involving myeloid cell 6-phosphofructo-2-kinase\/fructose-2,6-biphosphatase 3","volume":"72","author":"Ma","year":"2020","journal-title":"Hepatology"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1128\/mbio.03688-21","article-title":"Interleukin-17 weakens the NAFLD\/NASH process by facilitating intestinal barrier restoration depending on the gut microbiota","volume":"13","author":"He","year":"2022","journal-title":"mBio"},{"key":"B5","doi-asserted-by":"publisher","first-page":"514","DOI":"10.3390\/metabo12060514","article-title":"Interactions between tryptophan metabolism, the gut microbiome and the immune system as potential drivers of non-alcoholic fatty liver disease (NAFLD) and metabolic diseases","volume":"12","author":"Teunis","year":"2022","journal-title":"Metabolites"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11655-012-0993-2","article-title":"Chinese herbal medicine in the treatment of nonalcoholic fatty liver disease","volume":"18","author":"Dong","year":"2012","journal-title":"Chin J Integr Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1000727","article-title":"Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine","volume":"13","author":"Zhou","year":"2022","journal-title":"Front Endocrinol (Lausanne)."},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/184358","article-title":"Qushi huayu decoction inhibits hepatic lipid accumulation by activating AMP-activated protein kinase in vivo and in vitro","volume":"2013","author":"Feng","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1704960","article-title":"Research on the mechanism of Qushi Huayu decoction in the intervention of nonalcoholic fatty liver disease based on network pharmacology and molecular docking technology","volume":"2020","author":"Gao","year":"2020","journal-title":"BioMed Res Int"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/6242697","article-title":"Serum and liver tissue metabonomic study on fatty liver in rats induced by high-fat diet and intervention effects of traditional chinese medicine Qushi Huayu decoction","volume":"2017","author":"Gou","year":"2017","journal-title":"Evid Based Complement Alternat Med"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/5920485","article-title":"A metabolomic study on the intervention of traditional chinese medicine Qushi Huayu decoction on rat model of fatty liver induced by high-fat diet","volume":"2019","author":"Gou","year":"2019","journal-title":"BioMed Res Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2022.115806","article-title":"Inhibition on XBP1s-driven lipogenesis by Qushi Huayu Decoction contributes to amelioration of hepatic steatosis induced by fructose","volume":"301","author":"Tian","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2147\/dmso.S332659","article-title":"QSHY granules promote white adipose tissue browning and correct BCAAs metabolic disorder in NAFLD mice","volume":"14","author":"Zhang","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1080\/13880209.2022.2134898","article-title":"Qushi Huayu decoction attenuated hepatic lipid accumulation via JAK2\/STAT3\/CPT-1A-related fatty acid \u03b2-oxidation in mice with non-alcoholic steatohepatitis","volume":"60","author":"Sun","year":"2022","journal-title":"Pharm Biol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2019.153135","article-title":"Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway","volume":"66","author":"Leng","year":"2020","journal-title":"Phytomedicine"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0062885","article-title":"Molecular characterization of the fecal microbiota in patients with nonalcoholic steatohepatitis\u2013a longitudinal study","volume":"8","author":"Wong","year":"2013","journal-title":"PloS One"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2019.08.005","article-title":"Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development","volume":"71","author":"Mouries","year":"2019","journal-title":"J Hepatol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-019-0304-5","article-title":"Indole-3-propionic acid inhibits gut dysbiosis and endotoxin leakage to attenuate steatohepatitis in rats","volume":"51","author":"Zhao","year":"2019","journal-title":"Exp Mol Med"},{"key":"B20","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.freeradbiomed.2019.05.029","article-title":"Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease","volume":"144","author":"Svegliati-Baroni","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2016.89","article-title":"The multifaceted roles of fatty acid synthesis in cancer","volume":"16","author":"R\u00f6hrig","year":"2016","journal-title":"Nat Rev Cancer."},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2017.11.014","article-title":"Lipotoxicity and the gut-liver axis in NASH pathogenesis","volume":"68","author":"Marra","year":"2018","journal-title":"J Hepatol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.taap.2011.05.022","article-title":"Lipidomic changes in rat liver after long-term exposure to ethanol","volume":"255","author":"Fernando","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"e23109","DOI":"10.1002\/jcla.23109","article-title":"Lipidomic profiling of amniotic fluid and its application in fetal lung maturity prediction","volume":"34","author":"Cao","year":"2020","journal-title":"J Clin Lab Anal"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.4724","article-title":"High-throughput lipidomics analysis to discover lipid biomarkers and profiles as potential targets for evaluating efficacy of Kai-Xin-San against APP\/PS1 transgenic mice based on UPLC-Q\/TOF-MS","volume":"34","author":"Zhang","year":"2020","journal-title":"BioMed Chromatogr"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jff.2022.105341","article-title":"Hepatic lipidomics and proteomics analysis reveals the mechanism of Cyclocarya paliurus flavonoids in preventing non-alcoholic steatohepatitis in mice","volume":"99","author":"Wang","year":"2022","journal-title":"J Funct Foods."},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0012.7902","article-title":"miR-182-5p attenuates high-fat -diet-induced nonalcoholic steatohepatitis in mice","volume":"18","author":"Liang","year":"2019","journal-title":"Ann Hepatol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2019.01.029","article-title":"Interactions between gut microbiota and non-alcoholic liver disease: The role of microbiota-derived metabolites","volume":"141","author":"Ding","year":"2019","journal-title":"Pharmacol Res"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-020-0269-9","article-title":"Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disorders","volume":"17","author":"Aron-Wisnewsky","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5214","DOI":"10.3390\/ijms21155214","article-title":"Gut microbiota metabolites in NAFLD pathogenesis and therapeutic implications","volume":"21","author":"Chen","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.3390\/biomedicines8110501","article-title":"The gut microbiota: how does it influence the development and progression of liver diseases","volume":"8","author":"Kanmani","year":"2020","journal-title":"Biomedicines"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1097\/hep.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2023.04.036","article-title":"Changing epidemiology, global trends and implications for outcomes of NAFLD","volume":"79","author":"Wong","year":"2023","journal-title":"J Hepatol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.syapm.2012.12.009","article-title":"Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula","volume":"36","author":"Yin","year":"2013","journal-title":"Syst Appl Microbiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.15482","article-title":"Multi-targeting therapeutic mechanisms of the Chinese herbal medicine QHD in the treatment of non-alcoholic fatty liver disease","volume":"8","author":"Feng","year":"2017","journal-title":"Oncotarget"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01399","article-title":"Geniposide and chlorogenic acid combination ameliorates non-alcoholic steatohepatitis involving the protection on the gut barrier function in mouse induced by high-fat diet","volume":"9","author":"Peng","year":"2018","journal-title":"Front Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.4751","article-title":"Chlorogenic acid exhibits cholesterol lowering and fatty liver attenuating properties by up-regulating the gene expression of PPAR-\u03b1 in hypercholesterolemic rats induced with a high-cholesterol diet","volume":"27","author":"Wan","year":"2013","journal-title":"Phytother Res"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.105170","article-title":"Scoparone as a therapeutic drug in liver diseases: Pharmacology, pharmacokinetics and molecular mechanisms of action","volume":"160","author":"Hui","year":"2020","journal-title":"Pharmacol Res"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.5631","article-title":"Emodin: A review of its pharmacology, toxicity and pharmacokinetics","volume":"30","author":"Dong","year":"2016","journal-title":"Phytother Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0010.5273","article-title":"Curcumin in hepatobiliary disease: pharmacotherapeutic properties and emerging potential clinical applications","volume":"16","author":"Hu","year":"2017","journal-title":"Ann Hepatol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3945\/an.116.013151","article-title":"Nonalcoholic fatty liver disease, the gut microbiome, and diet","volume":"8","author":"Mokhtari","year":"2017","journal-title":"Adv Nutr"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbagen.2017.03.017","article-title":"Modulation of gut microbiota contributes to curcumin-mediated attenuation of hepatic steatosis in rats","volume":"1861","author":"Feng","year":"2017","journal-title":"Biochim Biophys Acta Gen Subj."},{"key":"B43","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/microorganisms9050957","article-title":"Gut microbiota and NAFLD: pathogenetic mechanisms, microbiota signatures, and therapeutic interventions","volume":"9","author":"Hrncir","year":"2021","journal-title":"Microorganisms"},{"key":"B44","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s40168-021-01125-7","article-title":"Commensal microbe-derived acetate suppresses NAFLD\/NASH development via hepatic FFAR2 signalling in mice","volume":"9","author":"Aoki","year":"2021","journal-title":"Microbiome"},{"key":"B45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12944-022-01711-0","article-title":"Potential novel biomarkers in small intestine for obesity\/obesity resistance revealed by multi-omics analysis","volume":"21","author":"Pang","year":"2022","journal-title":"Lipids Health Dis"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2021.110530","article-title":"Spirulina platensis polysaccharides attenuate lipid and carbohydrate metabolism disorder in high-sucrose and high-fat diet-fed rats in association with intestinal microbiota","volume":"147","author":"Li","year":"2021","journal-title":"Food Res Int"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2021.104966","article-title":"Anti-inflammatory effect of luteolin is related to the changes in the gut microbiota and contributes to preventing the progression from simple steatosis to nonalcoholic steatohepatitis","volume":"112","author":"Sun","year":"2021","journal-title":"Bioorg Chem"},{"key":"B48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","article-title":"Gut metagenome in European women with normal, impaired and diabetic glucose control","volume":"498","author":"Karlsson","year":"2013","journal-title":"Nature"},{"key":"B49","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3390\/nu12103100","article-title":"Microbiota, fiber, and NAFLD: is there any connection","volume":"12","author":"P\u00e9rez-Montes de Oca","year":"2020","journal-title":"Nutrients"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.tibs.2016.08.010","article-title":"Lipidomics: techniques, applications, and outcomes related to biomedical sciences","volume":"41","author":"Yang","year":"2016","journal-title":"Trends Biochem Sci"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2022.913729","article-title":"Modulation of the gut microbiota and lipidomic profiles by black chokeberry (Aronia melanocarpa L.) polyphenols via the glycerophospholipid metabolism signaling pathway","volume":"9","author":"Zhu","year":"2022","journal-title":"Front Nutr"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodchem.2022.133676","article-title":"UHPLC-Q-Exactive Orbitrap MS\/MS-based untargeted lipidomics reveals molecular mechanisms and metabolic pathways of lipid changes during golden pomfret (Trachinotus ovatus) fermentation","volume":"396","author":"Wang","year":"2022","journal-title":"Food Chem"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamem.2017.04.006","article-title":"The critical role of phosphatidylcholine and phosphatidylethanolamine metabolism in health and disease","volume":"1859","author":"van der Veen","year":"2017","journal-title":"Biochim Biophys Acta Biomembr."},{"key":"B54","doi-asserted-by":"publisher","first-page":"24","DOI":"10.3168\/jds.2022-21938","article-title":"Graduate Student Literature Review: A scoping review on the impact of consumption of dairy products on phosphatidylcholine and lysophosphatidylcholine in circulation and the liver in human studies and animal models","volume":"106","author":"Yuzbashian","year":"2023","journal-title":"J Dairy Sci"},{"key":"B55","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.3390\/ijms20051149","article-title":"An updated review of lysophosphatidylcholine metabolism in human diseases","volume":"20","author":"Law","year":"2019","journal-title":"Int J Mol Sci"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2011.02.004","article-title":"Mechanisms of glycerophospholipid homeostasis in mammalian cells","volume":"50","author":"Hermansson","year":"2011","journal-title":"Prog Lipid Res"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cphy.c170012","article-title":"Triglyceride metabolism in the liver","volume":"8","author":"Alves-Bezerra","year":"2017","journal-title":"Compr Physiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2017.03.005","article-title":"Sphingolipids and lipoproteins in health and metabolic disorders","volume":"28","author":"Iqbal","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-021-00502-9","article-title":"Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests","volume":"18","author":"Masoodi","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2021.2004578","article-title":"Probiotics act as a potent intervention in improving lipid profile: An umbrella systematic review and meta-analysis","volume":"63","author":"Zarezadeh","year":"2023","journal-title":"Crit Rev Food Sci Nutr"},{"key":"B61","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1038\/s41467-018-05767-4","article-title":"The gut microbiota promotes hepatic fatty acid desaturation and elongation in mice","volume":"9","author":"Kindt","year":"2018","journal-title":"Nat Commun"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.foodres.2019.03.055","article-title":"Fermented Momordica charantia L. juice modulates hyperglycemia, lipid profile, and gut microbiota in type 2 diabetic rats","volume":"121","author":"Gao","year":"2019","journal-title":"Food Res Int"},{"key":"B63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1880220","article-title":"The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites","volume":"13","author":"Meng","year":"2021","journal-title":"Gut Microbes"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2020-323715","article-title":"Dietary macronutrients and the gut microbiome: a precision nutrition approach to improve cardiometabolic health","volume":"71","author":"Jardon","year":"2022","journal-title":"Gut"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1272214\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T10:48:03Z","timestamp":1697021283000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1272214\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,11]]},"references-count":64,"alternative-id":["10.3389\/fendo.2023.1272214"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1272214","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,11]]},"article-number":"1272214"}}